guest ::
| Home > Publications database > Acute expression of human APOBEC3B in mice results in RNA editing and lethality. > print |
| Home > Publications database > Acute expression of human APOBEC3B in mice results in RNA editing and lethality. > print |
| 001 | 285670 | ||
| 005 | 20240229155115.0 | ||
| 024 | 7 | _ | |a 10.1186/s13059-023-03115-4 |2 doi |
| 024 | 7 | _ | |a pmid:38001542 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC10668425 |2 pmc |
| 024 | 7 | _ | |a 1465-6906 |2 ISSN |
| 024 | 7 | _ | |a 1465-6914 |2 ISSN |
| 024 | 7 | _ | |a 1474-7596 |2 ISSN |
| 024 | 7 | _ | |a 1474-760X |2 ISSN |
| 024 | 7 | _ | |a altmetric:156768377 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2023-02493 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Alonso de la Vega, Alicia |0 P:(DE-He78)4c6aa22ff0ca8ef5faf7abe3e9716bdf |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a Acute expression of human APOBEC3B in mice results in RNA editing and lethality. |
| 260 | _ | _ | |a London |c 2023 |b BioMed Central |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1701181737_17546 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:B220#LA:B220# |
| 520 | _ | _ | |a RNA editing has been described as promoting genetic heterogeneity, leading to the development of multiple disorders, including cancer. The cytosine deaminase APOBEC3B is implicated in tumor evolution through DNA mutation, but whether it also functions as an RNA editing enzyme has not been studied.Here, we engineer a novel doxycycline-inducible mouse model of human APOBEC3B-overexpression to understand the impact of this enzyme in tissue homeostasis and address a potential role in C-to-U RNA editing. Elevated and sustained levels of APOBEC3B lead to rapid alteration of cellular fitness, major organ dysfunction, and ultimately lethality in mice. Importantly, RNA-sequencing of mouse tissues expressing high levels of APOBEC3B identifies frequent UCC-to-UUC RNA editing events that are not evident in the corresponding genomic DNA.This work identifies, for the first time, a new deaminase-dependent function for APOBEC3B in RNA editing and presents a preclinical tool to help understand the emerging role of APOBEC3B as a driver of carcinogenesis. |
| 536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a APOBEC3B |2 Other |
| 650 | _ | 7 | |a DNA damage |2 Other |
| 650 | _ | 7 | |a Mouse models |2 Other |
| 650 | _ | 7 | |a Mutations |2 Other |
| 650 | _ | 7 | |a RNA editing |2 Other |
| 650 | _ | 7 | |a Cytidine Deaminase |0 EC 3.5.4.5 |2 NLM Chemicals |
| 650 | _ | 7 | |a Minor Histocompatibility Antigens |2 NLM Chemicals |
| 650 | _ | 7 | |a DNA |0 9007-49-2 |2 NLM Chemicals |
| 650 | _ | 7 | |a APOBEC3B protein, human |0 EC 3.5.4.5 |2 NLM Chemicals |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a RNA Editing |2 MeSH |
| 650 | _ | 2 | |a Cytidine Deaminase: genetics |2 MeSH |
| 650 | _ | 2 | |a Cytidine Deaminase: metabolism |2 MeSH |
| 650 | _ | 2 | |a Mutation |2 MeSH |
| 650 | _ | 2 | |a Neoplasms: pathology |2 MeSH |
| 650 | _ | 2 | |a Minor Histocompatibility Antigens: genetics |2 MeSH |
| 650 | _ | 2 | |a Minor Histocompatibility Antigens: metabolism |2 MeSH |
| 650 | _ | 2 | |a DNA: metabolism |2 MeSH |
| 700 | 1 | _ | |a Temiz, Nuri Alpay |b 1 |
| 700 | 1 | _ | |a Tasakis, Rafail |0 P:(DE-He78)65976eb710a9a31556034061f78781d5 |b 2 |
| 700 | 1 | _ | |a Somogyi, Kalman |0 P:(DE-He78)1a99792a8cdba2d016336662bb5c1099 |b 3 |u dkfz |
| 700 | 1 | _ | |a Salgueiro, Lorena |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Zimmer, Eleni |0 P:(DE-He78)dd8afdb992341efdf1a1ce54d15e65f3 |b 5 |u dkfz |
| 700 | 1 | _ | |a Ramos, Maria |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Diaz-Jimenez, Alberto |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Chocarro, Sara |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Fernández-Vaquero, Mirian |0 P:(DE-HGF)0 |b 9 |
| 700 | 1 | _ | |a Stefanovska, Bojana |b 10 |
| 700 | 1 | _ | |a Reuveni, Eli |b 11 |
| 700 | 1 | _ | |a Ben-David, Uri |b 12 |
| 700 | 1 | _ | |a Stenzinger, Albrecht |b 13 |
| 700 | 1 | _ | |a Poth, Tanja |b 14 |
| 700 | 1 | _ | |a Heikenwälder, Mathias |0 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5 |b 15 |u dkfz |
| 700 | 1 | _ | |a Papavasiliou, Nina |0 P:(DE-HGF)0 |b 16 |
| 700 | 1 | _ | |a Harris, Reuben S |b 17 |
| 700 | 1 | _ | |a Sotillo, Rocio |0 0000-0002-0855-7917 |b 18 |e Last author |
| 773 | _ | _ | |a 10.1186/s13059-023-03115-4 |g Vol. 24, no. 1, p. 267 |0 PERI:(DE-600)2040529-7 |n 1 |p 267 |t Genome biology |v 24 |y 2023 |x 1465-6906 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:285670 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)4c6aa22ff0ca8ef5faf7abe3e9716bdf |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)65976eb710a9a31556034061f78781d5 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)1a99792a8cdba2d016336662bb5c1099 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)dd8afdb992341efdf1a1ce54d15e65f3 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 0000-0002-0855-7917 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-24 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b GENOME BIOL : 2022 |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-05-02T09:06:40Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-05-02T09:06:40Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-05-02T09:06:40Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-24 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-24 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b GENOME BIOL : 2022 |d 2023-10-24 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-10-24 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-10-24 |
| 920 | 2 | _ | |0 I:(DE-He78)B220-20160331 |k B220 |l B220 Molekulare Grundlagen thorakaler Tumoren |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B220-20160331 |k B220 |l B220 Molekulare Grundlagen thorakaler Tumoren |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)F180-20160331 |k F180 |l F180 Chronische Entzündung und Krebs |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)D150-20160331 |k D150 |l D150 Immundiversität |x 2 |
| 920 | 0 | _ | |0 I:(DE-He78)B220-20160331 |k B220 |l B220 Molekulare Grundlagen thorakaler Tumoren |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B220-20160331 |
| 980 | _ | _ | |a I:(DE-He78)F180-20160331 |
| 980 | _ | _ | |a I:(DE-He78)D150-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|